arrow
V

Vladimir V. Shuvaev

University of Pennsylvania
H指数:40
被引数:5,327

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

In vivo reprogramming of cytotoxic effector CD8 T cells via fractalkine-conjugated mRNA-LNPs

通过 fractalkine 偶联的 mRNA-LNP 对细胞毒性效应 CD8 T 细胞进行体内重编程

2026-05-080
PRE
Decoupling Physisorption from Chemisorption in Clickable Lipid Nanoparticles

将可点击脂质纳米颗粒中的物理吸附与化学吸附解耦

2026-02-010
OA
Targeting DNA-LNPs to Endothelial Cells Improves Expression Magnitude, Duration, and Specificity

将dna-lnp靶向内皮细胞可改善表达幅度,持续时间和特异性

2026-01-200
OAAI
Tailoring the adjuvanticity of lipid nanoparticles by PEG lipid ratio and phospholipid modifications

通过PEG脂质比例和磷脂修饰来定制脂质纳米颗粒的佐剂性

2025-06-230
PRE
Targeting lipid nanoparticles to the blood-brain barrier to ameliorate acute ischemic stroke

脂质纳米粒靶向血脑屏障改善急性缺血性脑卒中

2024-05-018
OAAI
Breast tumors interfere with endothelial TRAIL at the premetastatic niche to promote cancer cell seeding
2023-03-247
OAAI
Added to pre-existing inflammation, mRNA-lipid nanoparticles induce inflammation exacerbation (IE)
2022-04-0167
OAAI
Dual Affinity to RBCs and Target Cells (DART) Enhances Both Organ- and Cell Type-Targeting of Intravascular Nanocarriers
2022-03-1037
OA
Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood-brain barrier

纳米药物选择性靶向发炎的脑血管以增强血脑屏障

2020-01-31112
OAAI
PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake

外源mRNA的PECAM-1定向重新靶向提供了两个数量级的血管递送增强和肺中的表达,而与载脂蛋白E介导的摄取无关

2018-12-01136
OAAI
Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude

红细胞搭便车使纳米载体向选定器官的递送增加了几个数量级

2018-07-11294
OAAI